跳至主要内容
临床试验/JPRN-jRCTs031230568
JPRN-jRCTs031230568
招募中
3 期

The Vasopressin Loading for Refractory septic shock (VALOR) study: a single-center randomized controlled trial. - VAROLstudy

akamura Kensuke0 个研究点目标入组 250 人2024年1月15日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
akamura Kensuke
入组人数
250
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2024年1月15日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
akamura Kensuke

入排标准

入选标准

  • (1\) Age at enrollment is 20 years or older
  • (2\) Patients diagnosed with septic shock based on Sepsis\-3 (requiring noradrenaline or other hypertensive drugs to maintain an average blood pressure of 65 mmHg or higher despite adequate infusion load, and blood lactate level of 2 mmol/L or higher)
  • (3\) Patients receiving noradrenaline 0\.2 gamma or higher

排除标准

  • (1\) Participated in this clinical study in the past
  • (2\) Patients who are otherwise judged by the physician to be inappropriate for inclusion in the study
  • (3\) Patients for whom the administration of this drug is contraindicated
  • (4\) Patients who cannot find a surrogate and whose state of consciousness is not expected to improve

结局指标

主要结局

未指定

相似试验